Concentrix (CNXC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
3 Apr, 2026Executive summary
Q1 2026 revenue grew 5.4% year-over-year to $2.5 billion, driven by strong AI-enabled solutions, particularly the iX suite, and robust demand in banking, financial services, insurance, travel, retail, and e-commerce, though technology, consumer electronics, and healthcare declined.
Revenue and profitability were in line with guidance, but operating income and net income declined sharply due to higher costs, restructuring, and increased SG&A expenses.
AI-related wins, especially with the iX suite, saw significant growth, with annual contract value for AI solutions more than doubling quarter-on-quarter and major contracts closed with Fortune 50 clients.
Continued investment in proprietary technology, efficiency initiatives, and long-term programs is expected to support future revenue and margin growth.
CEO emphasized measurable client value from AI and a focus on long-term growth.
Financial highlights
Q1 2026 revenue was $2.5 billion, up 5.4% year-over-year (1.9% constant currency); non-GAAP operating income was $295 million, and adjusted EBITDA was $348.2 million with a 13.9% margin.
Non-GAAP diluted EPS was $2.61, down from $2.79 year-over-year; GAAP diluted EPS was $0.33, down from $1.04.
Adjusted free cash flow was negative $144.6 million, reflecting seasonal factors, higher capital expenditures, and timing of cash receipts.
Net debt at quarter-end was $4.51 billion; liquidity was nearly $1.4 billion, including $1.1 billion undrawn on the revolving credit facility.
Returned $65 million to shareholders in Q1 via share repurchases and dividends.
Outlook and guidance
Q2 2026 revenue expected between $2.46 billion and $2.485 billion, with constant currency growth of 1% to 2%; Q2 non-GAAP operating income guidance is $290 million to $300 million, and non-GAAP EPS expected between $2.57 and $2.69.
Full-year 2026 revenue guidance is $10.035 billion to $10.18 billion, with constant currency growth of 1.5% to 3.0%; non-GAAP operating income guidance is $1.24 billion to $1.29 billion.
Full-year adjusted free cash flow guidance reaffirmed at $630 million to $650 million.
Net leverage targeted to fall below 2.6x adjusted EBITDA by fiscal year-end.
Future cash dividends anticipated quarterly, subject to board approval and financial conditions.
Latest events from Concentrix
- All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 202626 Mar 2026 - Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing27 Feb 2026 - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing13 Feb 2026 - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing13 Feb 2026 - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 20243 Feb 2026 - Q1 growth strong, Webhelp integration on track, and generative AI seen as a major opportunity.CNXC
BofA Securities 2024 Global Technology Conference1 Feb 2026 - Revenue up 46% to $2.4B, but net income dropped to $16.6M on integration costs.CNXC
Q3 202420 Jan 2026 - Record revenue and cash flow in 2025 set the stage for further growth in 2026.CNXC
Q4 202513 Jan 2026 - FY24 revenue hit $9.62B with strong cash flow; FY25 set for margin and cash flow growth.CNXC
Q4 202410 Jan 2026